GAP NARROWING BETWEEN FACIAL FILLERS

The FDA will review both Medicis Pharmaceutical Corp.'s Restylane and Inamed Corp's Hylaform on November 21.

Related Videos
Related Content

Dermal Infusions and Injections Lead to Improved Skin Quality

March 31st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

The Weekly Roundup: March 27-31

March 31st 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

What's Trending in Skin Care: March 2023

March 31st 2023

Treating Dermatological Conditions by Going Beyond the Skin

March 31st 2023

Dermal Infusions and Injections Lead to Improved Skin Quality

March 31st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

The Weekly Roundup: March 27-31

March 31st 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

What's Trending in Skin Care: March 2023

March 31st 2023

Treating Dermatological Conditions by Going Beyond the Skin

March 31st 2023

Dermal Infusions and Injections Lead to Improved Skin Quality

March 31st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

The Weekly Roundup: March 27-31

March 31st 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

What's Trending in Skin Care: March 2023

March 31st 2023

Treating Dermatological Conditions by Going Beyond the Skin

March 31st 2023
© 2023 MJH Life Sciences

All rights reserved.